Celltrion Secures Japanese Approval for Xolair and Eylea Biosimilars
Celltrion announced on the 27th that it has obtained marketing authorization from Japan’s Ministry of Health, Labour and Welfare for two key...
Biowatch
Celltrion to Double Production Capacity with 1.2 Trillion Won Investment
Celltrion has announced a massive expansion across three of its major facilities in South Korea and the United States, aiming for a total drug...
GC Wellbeing Launches ECM Skin Booster ‘GCELLE Ribonne’
GC Wellbeing announced on the 25th that it has officially launched "GCELLE Ribonne" in Korea, a skin booster based on...
Daewoong Pharmaceutical to Distribute 'The Spirokit' Digital Pulmonary Function Tester
As pulmonary function testing is officially integrated into standard general health checkups this year, Daewoong...
Korea’s 40th New Drug ‘Nuviju’ Launches: A Three-Way Battle for the Double-Chin Market
Medytox is set to shake up the aesthetic medicine industry with the launch of "Nuviju," a new treatment for submental...
ABL Bio to Present Two Bispecific Antibody ADC Posters at AACR
ABL Bio announced on the 19th that it will participate in this year’s American Association for Cancer Research Annual...
Oscotec to Present Kidney Failure Treatment Candidate at World Congress of Nephrology in Japan
Oscotec announced on the 23rd that it will present animal-model proof-of-concept results for a new drug candidate...
Alteogen to Present Subcutaneous ADC Formulation Research at International Forum in June
Alteogen announced on the 23rd that it will present research results regarding subcutaneous dosing for antibody-drug...
HK inno.N’s ‘Ecnoglutide’: Can a Late Entrant’s “Hidden Card” Reshape the Obesity Market?
HK inno.N is fast-tracking the South Korean launch of ecnoglutide, a GLP-1 receptor agonist licensed from China’s...
Celltrion Secures Canadian Approval for ‘Steqeyma’ Autoinjector Formulation
Celltrion announced on March 20, 2026, that it has received additional approval from Health Canada for the autoinjector...